DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
169 hedge funds and large institutions have $1.27B invested in Dicerna Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 50 increasing their positions, 40 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
25% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 40
25% less call options, than puts
Call options by funds: $1.98M | Put options by funds: $2.65M
Holders
169
Holding in Top 10
4
Calls
$1.98M
Puts
$2.65M
Top Buyers
| 1 | +$44.2M | |
| 2 | +$27.8M | |
| 3 | +$21.9M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$18.2M |
| 5 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$13.5M |
Top Sellers
| 1 | -$71.6M | |
| 2 | -$47.4M | |
| 3 | -$35.3M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$17.6M |
| 5 |
BM
Bridger Management
New York
|
-$14.9M |